chr8-71351721-C-T

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_000503.6(EYA1):c.124+3061G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene EYA1 is a cancer driver gene (CancerMine: 2 driver citations). The variant allele was found at a cumulative frequency of 0.835 (AC=127,075) in the gnomAD database across 152,210 control chromosomes, including 53,098 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.864. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.83 ( 53098 hom., cov: 33)

Consequence

EYA1
NM_000503.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.17

Publications

16 publications found
Variant links:
Genes affected
EYA1 (HGNC:3519): (EYA transcriptional coactivator and phosphatase 1) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013]
EYA1 Gene-Disease associations (from GenCC):
  • branchio-oto-renal syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Orphanet
  • branchiootorenal syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • branchiootic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000503.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.864 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000503.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

EYA1 NM_000503.6
MANE Select
HGVSc / HGVSpc.124+3061G>A
Exon rankIntron 3 of 17
intron
Prot: NP_000494.2
EYA1 NM_001370333.1
HGVSc / HGVSpc.211+3061G>A
Exon rankIntron 4 of 18
intron
Prot: NP_001357262.1UniProt: A0A2R8Y6K4
EYA1 NM_001370334.1
HGVSc / HGVSpc.124+3061G>A
Exon rankIntron 5 of 19
intron
Prot: NP_001357263.1UniProt: Q99502-1

Ensembl Transcripts

EYA1 ENST00000340726.8
TSL:1MANE Select
HGVSc / HGVSpc.124+3061G>A
Exon rankIntron 3 of 17
intron
Prot: ENSP00000342626.3UniProt: Q99502-1
EYA1 ENST00000388742.8
TSL:1
HGVSc / HGVSpc.124+3061G>A
Exon rankIntron 2 of 16
intron
Prot: ENSP00000373394.4UniProt: Q99502-1
EYA1 ENST00000419131.6
TSL:1
HGVSc / HGVSpc.124+3061G>A
Exon rankIntron 2 of 15
intron
Prot: ENSP00000410176.1UniProt: Q99502-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.835
AC:126993
Hom:53072
AN:152092
Cov:33
GnomAD4 genome
AF: 0.835
AC:127075
Hom:53098
AN:152210
Cov:33
TOPMed (Bravo)
AF: 0.835
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.829
AC:581566
Hom:241624
AN:701324
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.839
AC:1965
Hom:826
AN:2342
ChinaMAP Phase 1
AF: 0.863
Denmark Genome
AF: 0.817
AC:245
AN:300
Korea4K (4,157 Koreans)
AF: 0.860
AC:6218
AN:7228
Qatari Genome
AF: 0.920
AC:162
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.845
AC:103348
Hom:43671
AN:122260
Turkish Variome
AF: 0.867
AC:1340
Hom:579
AN:1546
UK10K
AF: 0.813
AC:6148
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.858
AC:7691
Hom:3296
AN:8960
Showing 13 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain14
BayesDel_noAF
Benign-0.29
CADD
Benign18
DANN
Benign0.65
GPN-Star LLR
N/A8.3
GPN-Star score
N/A3.9
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign1.2
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.